Arkados Group, Inc. Reports Fiscal First Quarter 2017 Results
Nov 02, 2016 12:00 pm UTC| Business
NEWARK, N.J., Nov. 02, 2016 -- Arkados Group, Inc. (OTCQB:AKDS), a global provider of scalable and interoperable Internet of Things (IoT) solutions focused on industrial automation and energy management, today announced...
Portola Pharmaceuticals to Present at the Credit Suisse 25th Annual Healthcare Conference
Nov 02, 2016 12:00 pm UTC| Business
SOUTH SAN FRANCISCO, Calif. , Nov. 02, 2016 -- Portola Pharmaceuticals (Nasdaq:PTLA) today announced that Bill Lis, chief executive officer, will present at the Credit Suisse 24th Annual Healthcare Conference on...
Stillwater Mining Company to Participate in the Goldman Sachs Global Metals and Mining Conference
Nov 02, 2016 12:00 pm UTC| Business
LITTLETON, Colo., Nov. 02, 2016 -- Stillwater Mining Company (NYSE:SWC) announced today that Mick McMullen, the Company’s President and Chief Executive Officer will participate in the Goldman Sachs Annual Metals and...
Yeast Market Globally to reach USD4.86 Billion by 2021, according to Zion Market Research
Nov 02, 2016 12:00 pm UTC| Business
Sarasota, FL, Nov. 02, 2016 -- Zion Research has published a new report titled “Yeast Market by Form (Instant, Fresh and Dry Yeast), by Type (Brewers, Bakers, Bio-ethanol, Wine, Feed and Other type), by Specialty Yeast...
LivaNova Reports Third Quarter 2016 Results
Nov 02, 2016 11:46 am UTC| Business
LONDON, Nov. 02, 2016 -- LivaNova PLC (NASDAQ:LIVN)(LSE:LIVN) (“LivaNova” or the “Company”), a market-leading medical technology and innovation company, today reported results for the third quarter ended September 30,...
Neuralstem Announces Presentations at Upcoming Scientific Conferences
Nov 02, 2016 11:35 am UTC| Business
GERMANTOWN, Md., Nov. 02, 2016 -- Neuralstem, Inc. (Nasdaq:CUR), a biopharmaceutical company focused on the development of central nervous system therapies based on its neural stem cell technology, announced poster...
Affimed Reports Financial Results for Third Quarter 2016
Nov 02, 2016 11:34 am UTC| Business
Heidelberg, Germany, Nov. 02, 2016 -- Heidelberg, Germany, November 2, 2016 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer...